Nirmatrelvir treatment duration and frequency of COVID-19 rebound.
- Published in:
- Antiviral Therapy, 2025, v. 30, n. 1, p. 1, doi. 10.1177/13596535251323728
- By:
- Publication type:
- Article
Works matching IS 13596535 AND DT 2025 AND VI 30 AND IP 1
Results: 3
1
2
Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir.
- Published in:
- Antiviral Therapy, 2025, v. 30, n. 1, p. 1, doi. 10.1177/13596535251314571
- By:
- Publication type:
- Article
3
Clinical outcomes among COVID-19 patients initiated on molnupiravir in Denmark – A national registry study.
- Published in:
- Antiviral Therapy, 2025, v. 30, n. 1, p. 1, doi. 10.1177/13596535241313244
- By:
- Publication type:
- Article